Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (191-200 of 333) with videos related to

Pageof 34
Sort By:
Cancer|August 1, 1980
Evaluation of vindesine and MER in colorectal cancerA Y Bedikian, M Valdivieso, J Maroun, et al.
Cancer|January 15, 1992
Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastasesG M Mavligit, A A Zukiwski, C Charnsangavej, et al.
Cancer Research|October 1, 1986
Activation or suppression of the tumoricidal properties of monocytes from cancer patients following treatment with human recombinant gamma-interferonE S Kleinerman, R Kurzrock, D Wyatt, et al.
Annals of Internal Medicine|July 1, 1978
Nephrotoxicity from cancer immunotherapyG M Dosik, J U Gutterman, E M Hersh, et al.
Experimental Hematology|August 1, 1988
Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factorH E Broxmeyer, S Cooper, D E Williams, et al.
Journal of the National Cancer Institute|August 1, 1974
Human immune response to active immunization with Rauscher leukemia virus. II. Humoral immunityE M Hersh, M G Hanna, J U Gutterman, et al.
The New England Journal of Medicine|April 24, 1986
Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemiaM Talpaz, H M Kantarjian, K McCredie, et al.
Archives of Internal Medicine|June 1, 1985
High rate of long-term survival in adult acute leukemia following ten-day chemotherapy (OAP) induction. Maintenance with chemotherapy or chemotherapy plus BCG vaccineJ S Hewlett, T Chen, S P Balcerzak, et al.
American Journal of Hematology|February 1, 1982
Human leukocyte interferon-mediated granulopoietic differentiation arrest and its abrogation by lithium carbonateD S Verma, G Spitzer, J U Gutterman, et al.
Cancer Research|March 1, 1992
Interferon-stimulated genes in interferon-sensitive and -resistant chronic myelogenous leukemia patientsM Talpaz, Y Chernajovsky, K Troutman-Worden, et al.
Pageof 34

Showing results (191-200 of 333) with videos related to

Sort By:
Pageof 34
Cancer|August 1, 1980
Evaluation of vindesine and MER in colorectal cancerA Y Bedikian, M Valdivieso, J Maroun, et al.
Cancer|January 15, 1992
Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastasesG M Mavligit, A A Zukiwski, C Charnsangavej, et al.
Cancer Research|October 1, 1986
Activation or suppression of the tumoricidal properties of monocytes from cancer patients following treatment with human recombinant gamma-interferonE S Kleinerman, R Kurzrock, D Wyatt, et al.
Annals of Internal Medicine|July 1, 1978
Nephrotoxicity from cancer immunotherapyG M Dosik, J U Gutterman, E M Hersh, et al.
Experimental Hematology|August 1, 1988
Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factorH E Broxmeyer, S Cooper, D E Williams, et al.
Journal of the National Cancer Institute|August 1, 1974
Human immune response to active immunization with Rauscher leukemia virus. II. Humoral immunityE M Hersh, M G Hanna, J U Gutterman, et al.
The New England Journal of Medicine|April 24, 1986
Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemiaM Talpaz, H M Kantarjian, K McCredie, et al.
Archives of Internal Medicine|June 1, 1985
High rate of long-term survival in adult acute leukemia following ten-day chemotherapy (OAP) induction. Maintenance with chemotherapy or chemotherapy plus BCG vaccineJ S Hewlett, T Chen, S P Balcerzak, et al.
American Journal of Hematology|February 1, 1982
Human leukocyte interferon-mediated granulopoietic differentiation arrest and its abrogation by lithium carbonateD S Verma, G Spitzer, J U Gutterman, et al.
Cancer Research|March 1, 1992
Interferon-stimulated genes in interferon-sensitive and -resistant chronic myelogenous leukemia patientsM Talpaz, Y Chernajovsky, K Troutman-Worden, et al.
Pageof 34